SPDR S&P Biotech ETF (XBI)
XBI is a passive ETF by State Street tracking the investment results of the S&P Biotechnology Select Industry Index. XBI launched on Feb 6, 2006 and has a 0.35% expense ratio.
ETF Info
| ISIN | US78464A8707 |
|---|---|
| CUSIP | 78464A870 |
| Issuer | State Street |
| Inception Date | Feb 6, 2006 |
| Region | North America (U.S.) |
| Category | Health & Biotech Equities |
| Leveraged | 1x |
| Index Tracked | S&P Biotechnology Select Industry Index |
| Home Page | www.ssga.com |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
XBI features an expense ratio of 0.35%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: XBI vs. IBB, XBI vs. LABU, XBI vs. ARKG, XBI vs. FBT, XBI vs. KWEB, XBI vs. IBBQ, XBI vs. VOO, XBI vs. BBH, XBI vs. BIB, XBI vs. ARKK
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in SPDR S&P Biotech ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
SPDR S&P Biotech ETF had a return of 8.23% year-to-date (YTD) and 22.72% in the last 12 months. Over the past 10 years, SPDR S&P Biotech ETF had an annualized return of 6.56%, while the S&P 500 had an annualized return of 10.55%, indicating that SPDR S&P Biotech ETF did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 8.23% | 13.39% |
| 1 month | 4.50% | 4.02% |
| 6 months | -2.33% | 5.56% |
| 1 year | 22.72% | 21.51% |
| 5 years (annualized) | 4.05% | 12.69% |
| 10 years (annualized) | 6.56% | 10.55% |
Monthly Returns
The table below presents the monthly returns of XBI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.08% | 12.57% | -3.59% | -10.82% | 5.33% | 4.15% | 6.85% | 2.22% | 8.23% | ||||
| 2023 | 7.11% | -6.81% | -8.01% | 5.24% | 4.64% | -0.86% | 1.31% | -6.04% | -7.80% | -9.30% | 14.03% | 18.25% | 7.60% |
| 2022 | -16.55% | -3.85% | 0.06% | -17.86% | -6.84% | 7.98% | 9.24% | 3.17% | -5.23% | 3.57% | 1.79% | -0.74% | -25.87% |
| 2021 | 8.59% | -3.19% | -8.32% | 0.72% | -6.24% | 5.70% | -8.86% | 7.64% | -5.37% | -0.72% | -6.84% | -3.71% | -20.45% |
| 2020 | -6.30% | 0.07% | -13.16% | 20.60% | 10.89% | 8.12% | -2.34% | 2.27% | -0.26% | 1.20% | 18.12% | 5.82% | 48.33% |
| 2019 | 16.52% | 6.63% | 1.57% | -5.90% | -6.76% | 10.41% | -2.31% | -6.20% | -5.12% | 7.06% | 14.72% | 1.56% | 32.56% |
| 2018 | 10.02% | -3.22% | -2.85% | -0.85% | 8.84% | 0.61% | 0.11% | 5.09% | -4.19% | -17.48% | 3.21% | -12.11% | -15.28% |
| 2017 | 9.65% | 8.18% | -1.21% | 3.03% | -5.22% | 14.16% | 1.28% | 7.24% | 3.31% | -3.38% | -0.54% | 2.06% | 43.77% |
| 2016 | -27.99% | -5.24% | 7.98% | 4.39% | 7.64% | -6.76% | 14.77% | -3.19% | 10.37% | -15.30% | 11.61% | -5.52% | -15.45% |
| 2015 | 7.07% | 7.50% | 5.17% | -8.50% | 15.43% | 6.09% | 1.27% | -13.06% | -15.86% | 7.04% | 8.49% | -2.68% | 13.58% |
| 2014 | 15.37% | 8.99% | -12.79% | -9.65% | 2.77% | 16.86% | -5.06% | 10.77% | -3.35% | 9.89% | 4.91% | 3.97% | 44.97% |
| 2013 | 8.17% | -1.20% | 6.36% | 5.94% | 4.96% | -6.08% | 17.56% | -2.70% | 8.37% | -7.87% | 9.66% | -0.19% | 48.39% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of XBI is 29, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
SPDR S&P Biotech ETF granted a 0.13% dividend yield in the last twelve months. The annual payout for that period amounted to $0.13 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.13 | $0.02 | $0.00 | $0.04 | $0.28 | $0.00 | $0.20 | $0.20 | $0.15 | $0.43 | $0.67 | $0.07 |
Dividend yield | 0.13% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Monthly Dividends
The table displays the monthly dividend distributions for SPDR S&P Biotech ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.00 | $0.11 | |||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.02 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.18 | $0.28 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.01 | $0.20 |
| 2017 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.03 | $0.20 |
| 2016 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.02 | $0.15 |
| 2015 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.15 | $0.43 |
| 2014 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.16 | $0.67 |
| 2013 | $0.01 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.01 | $0.07 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the SPDR S&P Biotech ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SPDR S&P Biotech ETF was 63.89%, occurring on May 11, 2022. The portfolio has not yet recovered.
The current SPDR S&P Biotech ETF drawdown is 44.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -63.89% | Feb 9, 2021 | 317 | May 11, 2022 | — | — | — |
| -49.25% | Jul 20, 2015 | 144 | Feb 11, 2016 | 484 | Jan 12, 2018 | 628 |
| -37.59% | Aug 15, 2008 | 139 | Mar 5, 2009 | 533 | Apr 14, 2011 | 672 |
| -35.26% | Jun 21, 2018 | 129 | Dec 24, 2018 | 346 | May 11, 2020 | 475 |
| -29.07% | Feb 28, 2014 | 49 | May 8, 2014 | 120 | Oct 28, 2014 | 169 |
Volatility
Volatility Chart
The current SPDR S&P Biotech ETF volatility is 6.33%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.